Provided by Yoon & Yang LLC
Yoon & Yang’s market-leading Finance Practice provides comprehensive and expert advice to a full spectrum of financial institutions, including banks, financial holding companies, investment firms, insurance companies, structured finance companies, savings banks and trust companies.
Our team advises on a broad range of matters such as financial company M&As, IPOs and listing eligibility reviews, private equity, real estate financings and acquisitions, project and acquisition financings, and derivative products. We also counsel clients on financial company examinations and sanctions, internal control and compliance, financial disputes and litigation, unfair trade investigations and accounting reviews, and licenses or permits for financial businesses. Notably, we support clients in the rapidly expanding areas of financial consumer protection, anti-money laundering, and digital investment and fintech.
Leveraging a deep understanding of relevant laws, regulatory practices, and the fast-changing financial industry, our Finance Practice offers optimal, practical solutions. We provide clear interpretative and implementation guidance, helping clients navigate regulatory expectations. To deliver integrated regulatory and enforcement counseling, our practice draws on unparalleled regulatory insight and industry expertise, strengthened further by newly recruited professionals with specialized knowledge critical to developing new products and addressing complex regulatory challenges.
Provided by Chambers
The capital markets team at Yoon & Yang handles a range of debt and equity instructions; it is very experienced in IPOs and issuances of global and convertible bonds, and is well placed to advise on securitisation transactions. The team has additional expertise in handling contentious matters in relation to capital markets transactions and listings.
Yoon & Yang advised PDC*line Pharma on its Korean IPO.
Provided by Chambers
Yoon & Yang establish a comprehensive response strategy to provide clear solutions. The team's extensive consulting experience in related fields facilitates communication and quick feedback.
Yoon & Yang has extensive experience and is more client-centric compared to other law firms.
Yoon & Yang establish a comprehensive response strategy to provide clear solutions. The team's extensive consulting experience in related fields facilitates communication and quick feedback.
Yoon & Yang has extensive experience and is more client-centric compared to other law firms.
Provided by Chambers
Sung Woon Kang regularly advises domestic and foreign companies on KRX IPOs. He additionally assists companies with delisting mandates.
He is highly professional and very approachable. He handles both core and ad hoc matters willingly and always responds with care, as if it were his own matter.
Sung Woon provides high-quality reports based on a high understanding of Korean capital markets and IPOs.
Jin Kook Lee has extensive experience advising clients on equity capital markets transactions and is well versed in handling IPOs for both issuers and lead managers.
Provided by Yoon & Yang LLC
Hwang Lim Jang
Hyun Suk Jung
Head of Department
Jitaek Chung
Jiwon Karen Kwak
Minji Kim
Pilwoon Oh
Sang-Hyun Ahn
Head of Department
Sangman Kim
Seong Ju Lee
Sung Bin Jhung
Head of Department
Provided by Yoon & Yang LLC
Day1 Company Inc.
DongKoo Bio&Pharma Co. Ltd.
E8IGHT Co., Ltd
Eugene Shinyoung Corporate Restructuring Private Equity Fund
HB Investment Inc.
Hanwha Investment & Securities
Hyosung
KNR SYSTEMS Inc.
Kencoa Aerospace
Korea Investment & Securities
Korea Investment Corporation (KIC)
Korea Venture Investment Corporation (KVIC)
Lunit Inc.
NH Investment & Securities
Orum Therapeutics, Inc.
PDC*line Pharma S.A.
STIC Investments
Samsung Securities
Seoyoung E&T
Shinhan SKS Corporate Recovery Private Equity Fund
The Export and Import Bank of Korea (KEXIM)
The Korea Development Bank